The Research Topic will explore emerging technologies such as advanced MRI, fMRI, PET ... Parkinson’s Disease · Epilepsy and Seizures · Dyslexia · Dementia · Cerebral Aneurysm We encourage submissions ...
the researchers hypothesized that patients with severe inflammation in healthy lungs prior to immunotherapy are more likely ...
In a promising development for Alzheimer’s disease diagnostics, Veravas, Inc. and Phanes Biotech have announced their ...
Alzheimer disease (AD) is the sixth leading cause of death in the United States and is projected to affect over 13 million ...
Healthy obesity is defined as having a BMI of 25 kg/m² or higher without metabolic diseases or with only one metabolic ...
Dr Charles Vega believes that primary care will be the chief clinical setting for application of new blood-based biomarkers.
With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...
An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...
Should Alzheimer’s be diagnosed without symptoms? Proposal to rely on blood tests roils scientists
Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...
Researchers from the International Working Group recommend categorizing biomarker-positive, cognitively normal individuals as ...
Observations show distinct variations between the changes in optic nerve head (ONH) and the macula.
Weill Cornell Medicine researchers have received a five-year $6.2 million grant from the National Institute on Aging, part of the National Institutes of Health, to build a portable, high-resolution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback